🔎 Trials Near Me

Gara Jalqabaatti › Neurofibroma Plexiform › Distaarikii Koloombiyaa › Washington

Qorannoo klinikaalii Neurofibroma Plexiform Washington, DC keessatti

Qorannoo 7 Neurofibroma Plexiform f Washington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Umuriin 5 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT02544022

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

Namoota walitti qabaa jiraSadarkaa 1
  • Children's National Hospital, Washington D.C.
Umuriin 16 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06502171

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Umuriin 3 hanga 120 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06222203

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Namoota walitti qabaa jiraSadarkaa 1
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Umuriin 3 hanga 35 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT02390752

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

Namoota walitti qabaa jiraSadarkaa 2
  • Children's National Hospital, Washington D.C.
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT06541847

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

Namoota walitti qabaa jira
  • Children's National Medical Center, Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Umuriin 1 hanga 120 · Saalaa hunda · Haaromfame 09-Wax-2026 · NCT06507748

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Namoota walitti qabaa jiraSadarkaa 2
  • Children's National Hospital, Washington D.C.
  • National Cancer Institute/ National Institutes of Health, Bethesda · Miili 7 fagaatti
Umuriin 1 hanga 8 · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT06188741

Qorannoo Neurofibroma Plexiform magaalota biroo keessatti

Qorannoo biroo Washington keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.